Skip to main content
OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.210
+0.010 (0.83%)
At close: Apr 28, 2026, 4:00 PM EDT
1.180
-0.030 (-2.48%)
Pre-market: Apr 29, 2026, 7:40 AM EDT

OPKO Health Revenue

OPKO Health had revenue of $124.20M in the quarter ending March 31, 2026, a decrease of -17.18%. This brings the company's revenue in the last twelve months to $581.12M, down -15.71% year-over-year. In the year 2025, OPKO Health had annual revenue of $606.88M, down -14.90%.

Revenue (ttm)
$581.12M
Revenue Growth
-15.71%
P/S Ratio
1.58
Revenue / Employee
$255,439
Employees
2,275
Market Cap
918.47M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025606.88M-106.26M-14.90%
Dec 31, 2024713.14M-150.35M-17.41%
Dec 31, 2023863.50M-140.70M-14.01%
Dec 31, 20221.00B-770.52M-43.42%
Dec 31, 20211.77B339.31M23.64%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Myriad Genetics 824.50M
NeoGenomics 727.33M
Veracyte 517.15M
GeneDx Holdings 427.54M
CareDx 379.81M
Castle Biosciences 344.23M
Fulgent Genetics 322.67M
BillionToOne 305.11M
Revenue Rankings

OPK News

More News